+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lercanidipine"

Calcium Channel Blocker Market Report 2025 - Product Thumbnail Image

Calcium Channel Blocker Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Lercanidipine is a calcium channel blocker used to treat hypertension and other cardiovascular diseases. It works by relaxing the blood vessels, allowing blood to flow more easily and reducing the workload on the heart. It is usually taken once a day, with or without food. Common side effects include dizziness, headache, and fatigue. Lercanidipine is a widely used drug in the cardiovascular market. It is a popular choice for treating hypertension due to its efficacy and low risk of side effects. It is also used to treat other cardiovascular conditions such as angina and coronary artery disease. The lercanidipine market is highly competitive, with many pharmaceutical companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Novartis, Sanofi, and Merck. Other companies such as Mylan, Teva, and Sun Pharmaceuticals also offer lercanidipine products. Show Less Read more